|
|
 |
 |
|
|
 |
|
|
|
|
|
Biotech & HealthAs governments and private corporations increasingly recognise the benefits of investing in this dynamic and fast growing industry, specialist legal services have become far more important to organisations at all stages of their development. Whether your organisation is a start-up company, an established research and development institution, a university, a co-operative research centre or a multinational pharmaceutical company, Allens Arthur Robinson (AAR) is able to offer a specialist, fully integrated range of services. Our biotech and healthcare team brings together lawyers, patent attorneys and corporate advisers who have the experience, expertise and professional networks to assist in every aspect of your organisation's operation - from funding start ups to commercialising innovations in biomedical research to stock exchange listing and beyond. AAR is one of very few law firms in Australia which offers a one-stop-shop of legal, intellectual property and corporate advisory services to the biotech and healthcare industry. This streamlined service not only brings together the very best of people in the one firm; it also saves time and money. Experience you can count onOur team is comprised of a highly skilled range of lawyers, patent attorneys and corporate advisers, many of whom also hold qualifications in the health sciences, engineering and computer programming. For instance, our scientific qualifications include disciplines such as microbiology, pharmacy, genetics and chemistry. This gives our practice a powerful combination of technical, commercial and legal know-how. Our expertise in biotechnology builds upon decades of partnerships with some of Australia's major players in the health sector. We have extensive experience in establishing and structuring health practices and facilities, infrastructure projects, taxation, insurance, litigation as well as dealing with health technology issues. We also have extensive experience in advising on the patentability of biomedical research and other inventions as well as on the many issues that concern the development of a biotechnology enterprise - the management, protection and commercialisation of intellectual property assets; technology licensing; commercialisation strategies; collaborative research and clinical trial agreements; corporate governance; capital raising; company floats; mergers; acquisitions and joint ventures. We have also dealt extensively with:
Optimising opportunitiesWhether we're working with a spin off company, an international venture capital fund wishing to invest in a brilliant idea or a health infrastructure provider, we are focused on achieving optimal commercial outcomes. We are also focused on understanding your business and your commercial objectives. We deliver innovative and cutting edge solutions. Allens Arthur Robinson BioFirst Commercialisation AwardThe BioFirst Commercialisation Awards celebrate NSW successes in biotechnology commercialisation and aim to raise the profile of the NSW biotechnology industry and research sector. The annual BioFirst Commercialisation Award is presented to the NSW biotechnology company that achieves international success with a technology, product or service that has been developed with assistance through the NSW Department of State and Regional Development's BioBusiness program. AAR is a major sponsor of the award. We congratulate Neuromonics Pty Ltd, the winner of the Allens Arthur Robinson BioFirst Commercialisation Award 2006. Neuromonics has developed a device that desensitises the brain to the annoying ringing or humming sound in the ears caused by tinnitus by playing music which has been digitally modified to change the pitch and add background noise. Past winners:
|
|
|
 |
||||||||||||||||||||||||||||||||||||||||
 |
 |
|
|
||
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
